Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
93
93 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- Carboplatin AUC-5Phase 22 trials
Inhibrx Biosciences, Inc · Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer
- DNA VaccinePhase 22 trials
NEC Bio B.V · Triple Negative Breast Cancer, Malignant Melanoma, Melanoma (Skin)
- DOC1021Phase 22 trials
Diakonos Oncology Corporation · Glioblastoma (GBM), Refractory Melanoma
- GI-102Phase 22 trials
GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Soft Tissue Sarcoma (STS)
- JMT108Phase 22 trials
Shanghai JMT-Bio Inc. · Unresectable Locally Advanced or Metastatic Melanoma, Unresectable Locally Advanced or Metastatic Urinary Tract Tumors, Advanced Malignant Tumors
- KB707Phase 22 trials
Krystal Biotech, Inc. · Cancer, Melanoma Stage III, Melanoma Stage IV
- LM103 TILsPhase 22 trials
Suzhou BlueHorse Therapeutics Co., Ltd. · Advanced Melanoma, Non-Small Cell Lung Cancer
- QuavonlimabMK-1308Phase 22 trials
Merck & Co. · Melanoma, Advanced Non-Small Cell Lung Cancer
- RAPA-201 Rapamycin Resistant T CellsRAPA-201 cellsPhase 22 trials
Rapa Therapeutics LLC · Malignant Melanoma, Malignant Melanoma With Metastasis, Malignant Melanoma Stage IIIc
- TCC1727Phase 22 trials
Beijing Tide Pharmaceutical Co., Ltd · Patients with Advanced Solid Tumors, Solid Cancers, NSCLC (Advanced Non-small Cell Lung Cancer)
- TQB2916Phase 22 trials
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Soft Tissue Sarcoma, Melanoma, Pancreatic Cancer
- TRK-950Phase 22 trials
Toray Industries, Inc · Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
- AMT-253Phase 21 trial
Multitude Therapeutics Inc. · Malignant Melanoma, Advanced Solid Tumors
- AU-007Phase 21 trial
Aulos Bioscience, Inc. · Advanced Solid Tumor, Metastatic Cancer, Cutaneous Melanoma
- AZD6750Phase 21 trial
AstraZeneca · Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin)
- BI-1607Phase 21 trial
BioInvent International AB · Melanoma Metastatic, Melanoma of Skin, Melanoma BRAF V600E/K Mutated
- BI-1808Phase 21 trial
BioInvent International AB · Advanced Malignancies, Ovarian Cancer, T-cell Lymphoma
- CJRB-101Phase 21 trial
CJ Bioscience, Inc. · NSCLC, HNSCC, Melanoma
- DYP688Phase 21 trial
Novartis · Metastatic Uveal Melanoma
- ENV-501Phase 21 trial
Hummingbird Bioscience · Melanoma (Skin), Non Small Cell Lung Cancer, Breast Cancer
- EVX-01Phase 21 trial
Evaxion Biotech A/S · Melanoma Stage IV, Unresectable Melanoma
- Fixed cemiplimabPhase 21 trial
Regeneron · Melanoma
- GEN1042Phase 21 trial
Genmab · Malignant Solid Tumor, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
- GIM-531Phase 21 trial
Georgiamune Inc · Melanoma Stage IV, Solid Tumor
- GM103Phase 21 trial
GeneMedicine Co., Ltd. · Head and Neck Cancer, Malignant Melanoma, Colorectal Cancer
- HX009Phase 21 trial
Hangzhou Hanx Biopharmaceuticals, Ltd. · Biliary Tract Cancer, Melanoma
- IOV-3001Phase 21 trial
Iovance Biotherapeutics, Inc. · Unresectable Melanoma, Metastatic Melanoma, Ocular Melanoma
- IOV-4001Phase 21 trial
Iovance Biotherapeutics, Inc. · Unresectable Melanoma, Metastatic Melanoma, Stage III Non-small Cell Lung Cancer
- IPN01194Phase 21 trial
Ipsen · Melanoma, Head and Neck Squamous Cell Carcinoma, Pancreatic Ductal Adenocarcinoma
- KVA12123Phase 21 trial
Kineta Inc. · Cancer, Solid Tumor, Melanoma
- LTT462Phase 21 trial
Novartis · Melanoma
- N17350Phase 21 trial
Onchilles Pharma Inc · Neoplasms, Solid Tumor, Breast Neoplasms, Triple-Negative, Squamous Cell Carcinoma of Skin
- OBX-115Phase 21 trial
Obsidian Therapeutics, Inc. · Tumor Skin, Metastatic Melanoma, Melanoma
- OKI-179Phase 21 trial
OnKure, Inc. · RAS Mutation, NRAS Gene Mutation, Melanoma
- OPM-101Phase 21 trial
Oncodesign Precision Medicine · Advanced Melanoma
- OR502Phase 21 trial
OncoResponse, Inc. · Cancer, Tumor, Solid, Malignant Neoplasm
- PRTX007Phase 21 trial
Primmune Therapeutics, Inc. · Melanoma Stage III
- RBP-01Phase 21 trial
ReBio Pharma · Uveal Melanoma
- RLY-8161Phase 21 trial
Relay Therapeutics, Inc. · Advanced NRAS-Mutant Melanoma, Advanced NRAS-Mutant Solid Tumors, NRAS Mutation
- ST-067Phase 21 trial
Simcha IL-18, Inc. · Cancer, Solid Tumor, Melanoma
- ST101Phase 21 trial
Sapience Therapeutics · Glioblastoma, Melanoma Stage IV, Breast Cancer
- VMD-102Single agentPhase 21 trial
VM Discovery, Inc. · Hepatocellular Carcinoma (HCC), Metastatic Uveal Melanoma, Renal Cell Carcinoma (RCC)
- XP-102Phase 21 trial
Xynomic Pharmaceuticals, Inc. · Cancer, BRAF V600 Mutation, Melanoma
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.